J2327 Injection risankizumab-rzaa 1 milligrams
J-Codes
Also known as: risankizumab, Skyrizi, IL-23R antibody
Injection of risankizumab-rzaa, 1 milligram. A monoclonal antibody targeting interleukin-23 receptor.
Clinical Context
Used for moderate-to-severe plaque psoriasis and moderate-to-severe Crohn's disease. Risankizumab targets IL-23 receptor reducing inflammation.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.